M. Borre et al., TUMOR-CELL PROLIFERATION AND SURVIVAL IN PATIENTS WITH PROSTATE-CANCER FOLLOWED EXPECTANTLY, The Journal of urology, 159(5), 1998, pp. 1609-1614
Purpose: Prostate cancers have different biological potentials, and ag
gressive tumors are difficult to identify when still localized. Tumor
cell proliferation determined by MIB-1 expression has been suggested a
s an important predictor for outcome in several human cancers includin
g the prostate. We test the possible prognostic value of tumor cellula
r proliferation in prostate cancer patients treated with no intent to
cure. Materials and Methods: Formalin fixed, paraffin embedded tumor t
issue obtained at the time of diagnosis from 221 patients originating
from a well known complete Danish prostate cancer population was immun
ohistochemically investigated. The tumor cell proliferation rate was d
etermined using the MIB-1 antibody. Tumors were clinically localized i
n 57% of the patients. Results: Tumor cell proliferation rate expresse
d by the MIB-1 score significantly correlated with tumor stage (p < 0.
001) and malignancy grade (p < 0.001). The MIB-1 score, divided into l
ow and high by the median value, showed significant association with d
isease specific survival in the entire study population (p < 0.0001),
as well as in the 125 patients suffering from clinically localized dis
ease (p = 0.018). Multivariate analyses showed that MIB-1 was a signif
icant (p = 0.0003) prognostic factor in the entire population, includi
ng advanced disease stages. However, in the theoretically curable clin
ically localized subpopulation MIB-1 was not significant (p = 0.08) co
ntrary to histopathological grade (p = 0.02), erythrocyte sedimentatio
n rate (p = 0.02) and T classification (p = 0.035). Conclusions: Prost
ate tumor cell proliferation, expressed by MIB-1 immunoreactivity, dem
onstrated significant association with disease specific survival. Howe
ver, MIB-1 is a close alternative to histopathological grade in descri
bing the natural history of clinically localized prostate cancer. The
additional prognostic value and the practical consequence of tumor cel
l proliferation remain to be clarified.